Searchable abstracts of presentations at key conferences in endocrinology

ea0014p541 | (1) | ECE2007

Ketoconazole before transsphenoidal surgery in Cushing’s disease patiens as a good alternative to glucocorticoids perioperatory treatment

Venegas E , Soto A , Vazquez M , Guerrero R , Pumar A , Montero JM , Garcia N , Mangas MA , Leon A , Leal-Cerro A

Cushing’s disease is a debilitating endocrinopathy characterized by excessive cortisol levels in the blood which may be produced from tumours of the pituitary gland. The only way to achieve long term cure of Cushing’s disease is by Transphenoidal removal of the adenoma. ketoconazole, inhibit steroid (cortisol) production in the adrenal glands.The use of glucocorticids treatment before and after hypophisectomy is a classic management in the peri...

ea0026p597 | Clinical case reports | ECE2011

Use of our last pills of iopanoic acid in a 33-year-old patient in acute refractory pulmonary edema and thyroid storm: requiem for a useful therapeutic agent

Hoyos E Gomez , Novoa P de Miguel , Zorrilla C Montanez , de la Torre N Garcia , Freixes M Curras , Freire R Bover , Pascual A Calle , de la Vega I Runkle

Introduction: The contrast agents iopanoic acid and ipodate are potent inhibitors of thyroid function, reducing type I deodinase T3 generation, inhibiting thyroid liberation of T4 and T3, and T3 receptor binding, with off-label use in hyperthyroid emergencies. However, since the interruption of iopanoic acid production this year, neither agent is currently available in Spain.Case report: A 34-year-old male was ...